The Godrej Consumer Products (GCPL) stock gained over 6 per cent in early trade on hopes of a recovery in its Indonesian operations, upsides from premiumisation of its Household Insecticides (HI) segment and expansion of its personal care portfolio. The stock, however, gave up most of the gains ending about 1.5 per cent higher, in a weak market.
Hopes of a recovery in Indonesian business, which accounts for 16 per cent of overall revenues and 20 per cent of the company’s operating profits, has been the latest trigger for the stock. Since Q2FY20, the Indonesian constant currency sales growth has seen a declining trend for five consecutive quarters from 13 per cent to -2 per cent in the Q3FY21. The decline has been on account of macroeconomic challenges, intense competition and the impact of Covid.
Despite the inflationary cost pressures, the company expects to maintain operating profit margins in the Indonesia business. Margins are at 28 per cent and have risen 500 basis points over the last five years. In addition to price hikes, reduction in media costs, improving product mix and higher share of general trade/e-commerce is expected to support margins.
Analysts led by Abneesh Roy of Edelweiss Research say that GCPL’s strategy of launching innovative products at disruptive price points is set to bolster its growth amid tough macroeconomic conditions. They also expect domestic (India) margins to benefit from supply chain efficiencies led by Project PI.
The stock has already rallied (up 48 per cent) since the appointment of Sudhir Sitapati as MD and CEO on expectation of sustained growth and improved capital allocation. Analysts at Motilal Oswal Research believe that these gains are a first step in what could be a potentially massive revitalization of both earnings and return ratios over the next few years, leading to a sustained re-rating as well.
Given the recent gains, investors should await consistency in growth and margins over the next couple of quarters before considering the stock.